222 related articles for article (PubMed ID: 34306209)
1. MicroRNA-301a-3p promotes triple-negative breast cancer progression through downregulating MEOX2.
Liu H; Wang G
Exp Ther Med; 2021 Sep; 22(3):945. PubMed ID: 34306209
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
[TBL] [Abstract][Full Text] [Related]
3. Cip2a/miR-301a feedback loop promotes cell proliferation and invasion of triple-negative breast cancer.
Yin J; Chen D; Luo K; Lu M; Gu Y; Zeng S; Chen X; Song Y; Zhang Z; Zheng G; He Z; Liu H
J Cancer; 2019; 10(24):5964-5974. PubMed ID: 31762806
[TBL] [Abstract][Full Text] [Related]
4. miR-490-3p inhibits the growth and invasiveness in triple-negative breast cancer by repressing the expression of TNKS2.
Jia Z; Liu Y; Gao Q; Han Y; Zhang G; Xu S; Cheng K; Zou W
Gene; 2016 Nov; 593(1):41-47. PubMed ID: 27506313
[TBL] [Abstract][Full Text] [Related]
5. Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1.
Liu H; Wang Y; Li X; Zhang YJ; Li J; Zheng YQ; Liu M; Song X; Li XR
Tumour Biol; 2013 Jun; 34(3):1713-22. PubMed ID: 23430586
[TBL] [Abstract][Full Text] [Related]
6. miR-143-3p targeting LIM domain kinase 1 suppresses the progression of triple-negative breast cancer cells.
Li D; Hu J; Song H; Xu H; Wu C; Zhao B; Xie D; Wu T; Zhao J; Fang L
Am J Transl Res; 2017; 9(5):2276-2285. PubMed ID: 28559978
[TBL] [Abstract][Full Text] [Related]
7. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.
Li HY; Liang JL; Kuo YL; Lee HH; Calkins MJ; Chang HT; Lin FC; Chen YC; Hsu TI; Hsiao M; Ger LP; Lu PJ
Breast Cancer Res; 2017 Dec; 19(1):133. PubMed ID: 29258605
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of miRNA-3613-3p Enhances the Sensitivity of Triple Negative Breast Cancer to CDK4/6 Inhibitor Palbociclib.
Yu Y; Liao H; Xie R; Zhang Y; Zheng R; Chen J; Zhang B
Front Oncol; 2020; 10():590813. PubMed ID: 33330073
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA Linc00339 promotes triple-negative breast cancer progression through miR-377-3p/HOXC6 signaling pathway.
Wang X; Chen T; Zhang Y; Zhang N; Li C; Li Y; Liu Y; Zhang H; Zhao W; Chen B; Wang L; Yang Q
J Cell Physiol; 2019 Aug; 234(8):13303-13317. PubMed ID: 30618083
[TBL] [Abstract][Full Text] [Related]
10. LINC01096 knockdown inhibits progression of triple-negative breast cancer by increasing miR-3130-3p.
Wang GP; Mou ZL; Xu YY; Liu GX; Wang DM; Zhang HP
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7445-7456. PubMed ID: 31539132
[TBL] [Abstract][Full Text] [Related]
11. miR-483-3p suppresses the proliferation and progression of human triple negative breast cancer cells by targeting the HDAC8>oncogene.
Menbari MN; Rahimi K; Ahmadi A; Mohammadi-Yeganeh S; Elyasi A; Darvishi N; Hosseini V; Abdi M
J Cell Physiol; 2020 Mar; 235(3):2631-2642. PubMed ID: 31508813
[TBL] [Abstract][Full Text] [Related]
12. miRNA-21 promotes proliferation and invasion of triple-negative breast cancer cells through targeting PTEN.
Fang H; Xie J; Zhang M; Zhao Z; Wan Y; Yao Y
Am J Transl Res; 2017; 9(3):953-961. PubMed ID: 28386324
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-301a-3p suppressed the progression of hepatocellular carcinoma via targeting VGLL4.
Hu J; Ruan J; Liu X; Xiao C; Xiong J
Pathol Res Pract; 2018 Dec; 214(12):2039-2045. PubMed ID: 30322806
[TBL] [Abstract][Full Text] [Related]
14. The miR-124-3p/Neuropilin-1 Axis Contributes to the Proliferation and Metastasis of Triple-Negative Breast Cancer Cells and Co-Activates the TGF-β Pathway.
Zhang J; Zhang X; Li Z; Wang Q; Shi Y; Jiang X; Sun X
Front Oncol; 2021; 11():654672. PubMed ID: 33912463
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of miR-301a-3p promotes colorectal cancer cell proliferation and metastasis by targeting deleted in liver cancer-1 and runt-related transcription factor 3.
Zhang L; Zhang Y; Zhu H; Sun X; Wang X; Wu P; Xu X
J Cell Biochem; 2019 Apr; 120(4):6078-6089. PubMed ID: 30362160
[TBL] [Abstract][Full Text] [Related]
16. miR-331-3p Suppresses Cell Proliferation in TNBC Cells by Downregulating NRP2.
Zhao M; Zhang M; Tao Z; Cao J; Wang L; Hu X
Technol Cancer Res Treat; 2020; 19():1533033820905824. PubMed ID: 32174262
[TBL] [Abstract][Full Text] [Related]
17. miR-29b-3p promotes progression of MDA-MB-231 triple-negative breast cancer cells through downregulating TRAF3.
Zhang B; Shetti D; Fan C; Wei K
Biol Res; 2019 Jul; 52(1):38. PubMed ID: 31349873
[TBL] [Abstract][Full Text] [Related]
18. The microRNAs miR-200b-3p and miR-429-5p target the LIMK1/CFL1 pathway to inhibit growth and motility of breast cancer cells.
Li D; Wang H; Song H; Xu H; Zhao B; Wu C; Hu J; Wu T; Xie D; Zhao J; Shen Q; Fang L
Oncotarget; 2017 Oct; 8(49):85276-85289. PubMed ID: 29156719
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics identification of dysregulated microRNAs in triple negative breast cancer based on microRNA expression profiling.
Chen J; Chen Z; Huang J; Chen F; Ye W; Ding G; Wang X
Oncol Lett; 2018 Mar; 15(3):3017-3023. PubMed ID: 29435032
[TBL] [Abstract][Full Text] [Related]
20. Curcumin inhibits proteasome activity in triple-negative breast cancer cells through regulating p300/miR-142-3p/PSMB5 axis.
Liu L; Fu Y; Zheng Y; Ma M; Wang C
Phytomedicine; 2020 Nov; 78():153312. PubMed ID: 32866906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
